Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Wockhardt’s bioequivalence centre at Aurangabad receives zero observations from US FDA

expressbpdJune 14, 2019

Tag: WOCKHARDT , bioequivalence centre , FDA

PharmaSources Customer Service